$4.8M in Congress trades disclosed this week

During Tuesday's State of the Union, President Trump urged Congress to "pass the Stop Insider Trading Act without delay." The bill would ban members, their spouses, and dependents from buying individual stocks. The moment drew a rare bipartisan standing ovation, though the bill still faces an uncertain path forward. We'll be tracking every move on Quiver.

Track every trade in real time with Quiver Premium

On January 26, the SEC settled charges against Brian Suthoff, a Massachusetts resident who sold his entire position in Sage Therapeutics after learning from a company insider that the FDA had struck major depressive disorder from the proposed label of Sage's flagship drug, zuranolone. Suthoff had held those shares for more than two years. He dumped them right before Sage announced the FDA's decision on August 4, 2023. The stock fell 53%. His avoided losses: $19,680.

The Suthoff case is the smallest dollar amount the SEC has pursued in a stand-alone insider trading action in recent memory. It sends a clear message.

Want more stories like this in your inbox every week?

Nvidia solidified its standing as the primary beneficiary of the global AI infrastructure race, issuing a:

The U.S. Supreme Court struck down President Donald Trump’s sweeping global tariffs, ruling on Feb. 20, 2026 that the administration exceeded:

The Pentagon is ramping up pressure on defense contractors to disclose their dependence on Anthropic, signaling a potential rupture:

@quiverquant

SOMETHING’S COOKIN’! 🧑‍🍳 #quiverquant #geopolitics #military #investing #fyp